Showing results (141-150 of 174) with videos related to
Sort By:
Pageof 18
Gynecologic Oncology|July 25, 2017
Dose dense carboplatin paclitaxel improves progression free survival in patients with endometrial cancerLiron Kogan, Ido Laskov, Zainab Amajoud, et al.Journal of Surgical Oncology|July 12, 2022
Predicting recurrence and recurrence-free survival in high-grade endometrial cancer using machine learningSabrina Piedimonte, Tomer Feigenberg, Erik Drysdale, et al.Journal of the National Cancer Institute|July 17, 1998
Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumorsW H Gotlieb, E Friedman, R B Bar-Sade, et al.Gynecologic Oncology Reports|January 22, 2019
Gender differences in how physicians access and process informationR Gotlieb, J Abitbol, J A How, et al.Gynecologic Oncology Reports|June 20, 2018
Impact of lower uterine segment involvement in type II endometrial cancer and the unique mutational profile of serous tumorsLiron Kogan, David Octeau, Zainab Amajoud, et al.Journal of Surgical Oncology|April 16, 2020
The impact of wait times on oncological outcome in high-risk patients with endometrial cancerCristina Mitric, Emad Matanes, Michel Wissing, et al.Gynecologic Oncology|May 1, 2020
The added value of sentinel node mapping in endometrial cancerLiron Kogan, Emad Matanes, Michel Wissing, et al.Gynecologic Oncology|February 4, 2018
Distinct homologous recombination gene expression profiles after neoadjuvant chemotherapy associated with clinical outcome in patients with ovarian cancerRoy Kessous, David Octeau, Kathleen Klein, et al.Journal of Robotic Surgery|August 4, 2022
Impact of robotic surgery on patient flow and resource use intensity in ovarian cancerJeremie Abitbol, Beste Kucukyazici, Sonya Brin, et al.Gynecologic Oncology|July 28, 2019
Risk factors for lymph nodes involvement in obese women with endometrial carcinomasMichel Wissing, Cristina Mitric, Zainab Amajoud, et al.Pageof 18